Items where authors include "Wignall, A"

Article

Louette, S, Wignall, A and Pandit, H orcid.org/0000-0001-7392-8561 (2022) Spinopelvic relationship and its impact on total hip arthroplasty. Arthroplasty Today, 17. pp. 87-93. ISSN 2352-3441

Alzaid, A, Wignall, A, Dogramadzi, S et al. (2 more authors) (2022) Automatic detection and classification of peri-prosthetic femur fracture. International Journal of Computer Assisted Radiology and Surgery, 17 (4). pp. 649-660. ISSN 1861-6410

van Duren, BH, Wignall, A, Goodman, S et al. (3 more authors) (2022) The Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Drugs on the Risk of Postoperative Complications. The Journal of Bone and Joint Surgery. ISSN 0021-9355

van Duren, BH, Wignall, A, Rangan, A et al. (3 more authors) (2021) To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery? Rheumatology Advances in Practice, 5 (3). rkab057. ISSN 2514-1775

Wignall, A, Giannoudis, V, De, C et al. (6 more authors) (2021) The impact of COVID-19 on the management and outcomes of patients with proximal femoral fractures: a multi-centre study of 580 patients. Journal of Orthopaedic Surgery and Research, 16. 155. ISSN 1749-799X

De, C, Wignall, A, Giannoudis, V et al. (6 more authors) (2020) Peri-operative Outcomes and Predictors of Mortality in COVID-19 Positive Patients with Hip Fractures: A Multicentre Study in the UK. Indian Journal of Orthopaedics, 54 (S2). pp. 386-396. ISSN 0019-5413

Adamson, H, Nicholl, A, Tiede, C orcid.org/0000-0003-0280-4005 et al. (9 more authors) (2019) Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics. BioTechniques, 67 (6). ISSN 0736-6205